Shunsaku Nakagawa

7PUBLICATIONS
15CO-AUTHORS
Respiratory diseasesClinical pharmacy and pharmacy practiceChemical and thermal processes in energy and combustionCancer therapy (excl. chemotherapy and radiation therapy)Microbial ecology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 29, 2026
Risk of Heart Failure Hospitalization Associated With Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors Versus Erythropoiesis-Stimulating Agents: A Nationwide Claims-Based Cohort Study.

|Dec 24, 2025
Efficacy of protocol-based pharmacotherapy management in switching of antibiotic administration routes and dose adjustment based on renal function: a before-after study.

Yuki Sato, Yudai Takatani, Shunsaku Nakagawa

|Aug 18, 2025
CYP2C19-Guided Voriconazole Therapy: A Precision Medicine Approach to Mitigate Adverse Effects in Japanese Patients.

Yoshiki Katada, Daiki Hira, Keisuke Umemura

|Jul 17, 2025
Onco-nephrology in clinical practice: pharmacokinetics, monitoring, and treatment strategies for patients with cancer and impaired renal function.

Shunsaku Nakagawa, Keiko Ikuta, Takashi Masuda

|Aug 23, 2021
Antibiotic-induced microbiome depletion alters renal glucose metabolism and exacerbates renal injury after ischemia-reperfusion injury in mice.

Yuika Osada, Shunsaku Nakagawa, Kanako Ishibe

|Feb 16, 2021
Association of proton pump inhibitors and concomitant drugs with risk of acute kidney injury: a nested case-control study.

Keiko Ikuta, Shunsaku Nakagawa, Kenji Momo

Pageof 2

Frequent Collaborators

3 joint publications

Tomohiro Terada

2 joint publications

Atsushi Yonezawa

2 joint publications

Yoshiki Katada

2 joint publications

Daiki Hira